The short answer is no, you cannot outgrow asthma, but your symptoms may be less severe. Learn when asthma goes into ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very sensitive, ...

Nocturnal asthma and sleep apnoea can both disrupt sleep but the two conditions are different and have different causes ...

Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its ...

The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...

Emergency room visits for asthma-related symptoms increase during the cold months. Here's how to know when an asthma attack ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory ...

GREEN BAY, Wis. (WBAY) - The winter months may be known for an uptick in the flu and other viruses, but they’re also a challenging time for people with asthma, especially for kids. The dry, cold ...

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...